Home
Srdjan Djurovic's picture

Srdjan Djurovic

Professor
  • E-mailSrdjan.Djurovic@uib.no
  • Visitor Address
    Haukeland universitetssykehus, Laboratoriebygget
  • Postal Address
    Postboks 7804
    5020 Bergen
Academic article
  • 2019. The Relationship Between Polygenic Risk Scores and Cognition in Schizophrenia. Schizophrenia Bulletin. 9 pages.
  • 2019. Telomere length is associated with childhood trauma in patients with severe mental disorders. Translational Psychiatry. 7 pages.
  • 2019. Pleiotropic meta-analysis of cognition, education, and schizophrenia differentiates roles of early neurodevelopmental and adult synaptic pathways. American Journal of Human Genetics. 334-350.
  • 2019. Metabolic dysfunctions in the kynurenine pathway, noradrenergic and purine metabolism in schizophrenia and bipolar disorders. Psychological Medicine. 12 pages.
  • 2019. Inflammatory markers are altered in severe mental disorders independent of comorbid cardiometabolic disease risk factors. Psychological Medicine. 1749-1757.
  • 2019. Identification of genetic overlap and novel risk loci for attention-deficit/hyperactivity disorder and bipolar disorder. Molecular Psychiatry. 1-11.
  • 2019. Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk. Nature Genetics. 404-413.
  • 2019. Genome-wide association study identifies 30 loci associated with bipolar disorder. Nature Genetics. 793-803.
  • 2019. Genetic architecture of subcortical brain structures in 38,851 individuals. Nature Genetics. 1624-1636.
  • 2019. Genetic Overlap Between Alzheimer’s Disease and Bipolar Disorder Implicates the MARK2 and VAC14 Genes. Frontiers in Neuroscience. 11 pages.
  • 2019. GWASinlps: Non-local prior based iterative SNP selection tool for genome-wide association studies. Bioinformatics. 1-11.
  • 2019. GWAS of suicide attempt in psychiatric disorders and association with major depression polygenic risk scores. American Journal of Psychiatry. 651-660.
  • 2019. GBA and APOE ε4 associate with sporadic dementia with Lewy bodies in European genome wide association study. Scientific Reports.
  • 2019. Exploring lithium's transcriptional mechanisms of action in bipolar disorder: a multi-step study. Neuropsychopharmacology. 1-9.
  • 2019. Examining the association between genetic liability for schizophrenia and psychotic symptoms in Alzheimer's disease. Translational Psychiatry. 1-10.
  • 2019. Common brain disorders are associated with heritable patterns of apparent aging of the brain. Nature Neuroscience. 1617-1623.
  • 2019. Bivariate causal mixture model quantifies polygenic overlap between complex traits beyond genetic correlation. Nature Communications.
  • 2019. Attention-deficit hyperactivity disorder shares copy number variant risk with schizophrenia and autism spectrum disorder. Translational Psychiatry. 1-9.
  • 2019. Association of copy number variation of the 15q11.2 BP1-BP2 region with cortical and subcortical morphology and cognition. JAMA psychiatry. 11 pages.
  • 2019. Alterations in schizophrenia-associated genes can lead to increased power in delta oscillations. Cerebral Cortex. 875-891.
  • 2018. Vitamin D levels, brain volume, and genetic architecture in patients with psychosis. PLOS ONE. 17 pages.
  • 2018. The relationship between physical activity, clinical and cognitive characteristics and BDNF mRNA levels in patients with severe mental disorders. World Journal of Biological Psychiatry. 24 pages.
  • 2018. Study of 300,486 individuals identifies 148 independent genetic loci influencing general cognitive function. Nature Communications. 1-16.
  • 2018. Stability of the Brain Functional Connectome Fingerprint in Individuals With Schizophrenia. JAMA psychiatry.
  • 2018. Meta-analysis of Alzheimer’s disease on 9,751 samples from Norway and IGAP study identifies four risk loci. Scientific Reports. 8 pages.
  • 2018. In Vivo Two-Photon Voltage Imaging with Sulfonated Rhodamine Dyes. ACS Central Science. 1371-1378.
  • 2018. Improving genetic prediction by leveraging genetic correlations among human diseases and traits. Nature Communications. 1-17.
  • 2018. Immunomodulatory capacity of the serotonin receptor 5-HT2B in a subset of human dendritic cells. Scientific Reports. 1-12.
  • 2018. Identification of shared genetic variants between schizophrenia and lung cancer. Scientific Reports. 1-8.
  • 2018. Genomic Dissection of Bipolar Disorder and Schizophrenia, Including 28 Subphenotypes. Cell. 1705-1715.
  • 2018. Genome-wide association meta-analysis in 269,867 individuals identifies new genetic and functional links to intelligence. Nature Genetics. 912-919.
  • 2018. Genetic variation in 117 myelination-related genes in schizophrenia: Replication of association to lipid biosynthesis genes. Scientific Reports. 1-8.
  • 2018. Genetic factors influencing prostate cancer risk in Norwegian men. The Prostate. 186-192.
  • 2018. Expression of TCN1 in Blood is Negatively Associated with Verbal Declarative Memory Performance. Scientific Reports. 1-11.
  • 2018. Exploring the Wnt signaling pathway in schizophrenia and bipolar disorder. Translational Psychiatry. 1-10.
  • 2018. Elevated expression of a minor isoform of ANK3 is a risk factor for bipolar disorder. Translational Psychiatry. 1-10.
  • 2018. Deep 2-photon imaging and artifact-free optogenetics through transparent graphene microelectrode arrays. Nature Communications. 1-12.
  • 2018. Cross-tissue eQTL enrichment of associations in schizophrenia. PLOS ONE.
  • 2018. Common schizophrenia alleles are enriched in mutation-intolerant genes and in regions under strong background selection. Nature Genetics. 381-389.
  • 2018. Chronotype and cellular circadian rhythms predict the clinical response to lithium maintenance treatment in patients with bipolar disorder. Neuropsychopharmacology. 620-628.
  • 2018. Brain scans from 21,297 individuals reveal the genetic architecture of hippocampal subfield volumes. Molecular Psychiatry. 1-13.
  • 2018. Attenuated Notch signaling in schizophrenia and bipolar disorder. Scientific Reports. 1-8.
  • 2018. Associations between persistent organic pollutants and metabolic syndrome in morbidly obese individuals. NMCD. Nutrition Metabolism and Cardiovascular Diseases. 1-8.
  • 2018. Applying polygenic risk scoring for psychiatric disorders to a large family with bipolar disorder and major depressive disorder. Communications Biology. 10 pages.
  • 2018. An association between YKL-40 and type 2 diabetes in psychotic disorders. Acta Psychiatrica Scandinavica. 37-45.
  • 2018. A molecule-based genetic association approach implicates a range of voltage-gated calcium channels associated with schizophrenia. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics. 454-467.
  • 2017. Psychotic patients who used cannabis frequently before illness onset have higher genetic predisposition to schizophrenia than those who did not. Psychological Medicine. 43-49.
  • 2017. Novel loci associated with attention-deficit/hyperactivity disorder are revealed by leveraging polygenic overlap with educational attainment. Journal of the American Academy of Child and Adolescent Psychiatry. 86-95.
  • 2017. Leveraging genome characteristics to improve gene discovery for putamen subcortical brain structure. Scientific Reports. 1-9.
  • 2017. Large-scale cognitive GWAS meta-analysis reveals tissue-specific neural expression and potential nootropic drug targets. Cell reports. 2597-2613.
  • 2017. Identification of gene loci that overlap between schizophrenia and educational attainment. Schizophrenia Bulletin. 654-664.
  • 2017. Genome-wide association study of borderline personality disorder reveals genetic overlap with bipolar disorder, major depression and schizophrenia. Translational Psychiatry. e1155.
  • 2017. Genetic risk scores and family history as predictors of schizophrenia in Nordic registers. Psychological Medicine. 1201-1208.
  • 2017. GWAS meta-analysis reveals novel loci and genetic correlates for general cognitive function: a report form the COGENT consortium. Molecular Psychiatry. 336-345.
  • 2017. Fourteen sequence variants that associate with multiple sclerosis discovered by meta-analysis informed by genetic correlations. NPJ GENOMIC MEDICINE. 12 pages.
  • 2017. Combinations of genetic variants associated with bipolar disorder. PLOS ONE.
  • 2017. Analysis of the joint effect of SNPs to identify independent loci and allelic heterogeneity in schizophrenia GWAS data. Translational Psychiatry.
  • 2016. VRK2 gene expression in schizophrenia, bipolar disorder and healthy controls. British Journal of Psychiatry. 114-120.
  • 2016. Parents' attitudes toward genetic research in autism spectrum disorder. Psychiatric Genetics. 74-80.
  • 2016. Leveraging Genomic Annotations and Pleiotropic Enrichment for Improved Replication Rates in Schizophrenia GWAS. PLoS Genetics. 22 pages.
  • 2016. Inflammatory evidence for the psychosis continuum model. Psychoneuroendocrinology. 189-197.
  • 2016. Identification of rare high-risk copy number variants affecting the dopamine transporter gene in mental disorders. Nordic Journal of Psychiatry. 276-279.
  • 2016. Genome-wide autozygosity is associated with lower general cognitive ability. Molecular Psychiatry. 837-843.
  • 2016. Genetic overlap between multiple sclerosis and several cardiovascular disease risk factors. Multiple Sclerosis. 1783-1793.
  • 2016. Functional effects of schizophrenia-linked genetic variants on intrinsic single-neuron excitability: a modeling study. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging. 49-59.
  • 2016. Conservation of Distinct Genetically-Mediated Human Cortical Pattern. PLoS Genetics. 18 pages.
  • 2016. Cell type specificity of neurovascular coupling in cerebral cortex. eLIFE.
  • 2015. Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways. Nature Neuroscience.
  • 2015. Polygenic risk scores in bipolar disorders subgroups. Journal of Affective Disorders. 310-314.
  • 2015. Polygenic overlap between C-reactive protein, plasma lipids, and Alzheimer disease. Circulation. 2061-2069.
  • 2015. New data and an old puzzle: The negative association between schizophrenia and rheumatoid arthritis. International Journal of Epidemiology. 1706-1721.
  • 2015. Modeling Linkage Disequilibrium Increases Accuracy of Polygenic Risk Scores. American Journal of Human Genetics.
  • 2015. Microarray analysis of copy number variants on the human y chromosome reveals novel and frequent duplications overrepresented in specific haplogroups. PLOS ONE.
  • 2015. Large-scale genomics unveil polygenic architecture of human cortical surface area. Nature Communications.
  • 2015. LD score regression distinguishes confounding from polygenicity in genome-wide association studies. Nature Genetics. 291-295.
  • 2015. Joint analysis of psychiatric disorders increases accuracy of risk prediction for schizophrenia, bipolar disorder, and major depressive disorder. American Journal of Human Genetics. 283-294.
  • 2015. Independent evidence for an association between general cognitive ability and a genetic locus for educational attainment. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics. 363-373.
  • 2015. Identifying Novel Gene Variants in Coronary Artery Disease and Shared Genes with Several Cardiovascular Risk Factors. Circulation Research. 83-94.
  • 2015. Genome-wide association study identifies common variants associated with pharmacokinetics of psychotropic drugs. Journal of Psychopharmacology. 884-891.
  • 2015. Genetic sharing with cardiovascular disease risk factors and diabetes reveals novel bone mineral density loci. PLOS ONE.
  • 2015. Genetic overlap between Alzheimer's disease and Parkinson's disease at the MAPT locus. Molecular Psychiatry. 1588-1595.
  • 2015. Genetic Markers of Human Evolution Are Enriched in Schizophrenia. Biological Psychiatry.
  • 2015. Combinations of genetic data present in bipolar patients, but absent in control persons. PLOS ONE. 7 pages.
  • 2015. Association between altered brain morphology and elevated peripheral endothelial markers — Implications for psychotic disorders . Schizophrenia Research. 222-228.
  • 2015. Altered brain activation during emotional face processing in relation to both diagnosis and polygenic risk of bipolar disorder. PLOS ONE.
  • 2015. A Loss-of-Function Variant in a Minor Isoform of ANK3 Protects Against Bipolar Disorder and Schizophrenia. Biological Psychiatry.
  • 2014. Polygenic dissection of diagnosis and clinical dimensions of bipolar disorder and schizophrenia. Molecular Psychiatry. 1017-1024.
  • 2014. Molecular genetic evidence for overlap between general cognitive ability and risk for schizophrenia: A report from the Cognitive Genomics consorTium (COGENT). Molecular Psychiatry. 168-174.
  • 2014. Common variant at 16p11.2 conferring risk of psychosis. Molecular Psychiatry. 108-114.
  • 2014. Association analysis between suicidal behaviour and candidate genes of bipolar disorder and schizophrenia. Journal of Affective Disorders. 110-114.
  • 2013. ZNF804A and cortical thickness in schizophrenia and bipolar disorder. Psychiatry Research : Neuroimaging. 154-157.
  • 2013. Variant of TREM2 Associated with the Risk of Alzheimer's Disease. New England Journal of Medicine. 107-116.
  • 2013. Pathway analysis of genetic markers associated with a functional MRI faces paradigm implicates polymorphisms in calcium responsive pathways. NeuroImage. 143-149.
  • 2013. No evidence for association between bipolar disorder risk gene variants and brain structural phenotypes. Journal of Affective Disorders. 291-297.
  • 2013. Improved Detection of Common Variants Associated with Schizophrenia by Leveraging Pleiotropy with Cardiovascular-Disease Risk Factors. American Journal of Human Genetics. 197-209.
  • 2013. Improved Detection of Common Variants Associated with Schizophrenia and Bipolar Disorder Using Pleiotropy-Informed Conditional False Discovery Rate. PLoS Genetics. 16 pages.
  • 2013. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nature Genetics. 984-994.
  • 2013. CACNA1C Risk Variant and Amygdala Activity in Bipolar Disorder, Schizophrenia and Healthy Controls. PLOS ONE. 6 pages.
  • 2013. BDNF val66met modulates the association between childhood trauma, cognitive and brain abnormalities in psychoses. Progress in Neuro-psychopharmacology and Biological Psychiatry. 181-188.
  • 2013. A genetic deconstruction of neurocognitive traits in schizophrenia and bipolar disorder. PLOS ONE. 9 pages.
  • 2013. A comprehensive family-based replication study of schizophrenia genes. JAMA psychiatry. 573-581.
  • 2012. Up-Regulation of NOTCH4 Gene Expression in Bipolar Disorder. American Journal of Psychiatry. 1292-1300.
  • 2012. TCF4 sequence variants and mRNA levels are associated with neurodevelopmental characteristics in psychotic disorders. Translational Psychiatry.
  • 2012. Serotonin Transporter Gene Polymorphism, Childhood Trauma, and Cognition in Patients With Psychotic Disorders. Schizophrenia Bulletin. 15-22.
  • 2012. Replication Study and Meta-Analysis in European Samples Supports Association of the 3p21.1 Locus with Bipolar Disorder. Biological Psychiatry. 645-650.
  • 2012. Linkage-disequilibrium-based binning affects the interpretation of GWASs. American Journal of Human Genetics. 727-733.
  • 2012. Identification of common variants associated with human hippocampal and intracranial volumes. Nature Genetics. 552-561.
  • 2012. Genome-wide study identifies PTPRO and WDR72 and FOXQ1-SUMO1P1 interaction associated with neurocognitive function. Journal of Psychiatric Research. 271-278.
  • 2012. Genome-wide association study identifies genetic loci associated with body mass index and high density lipoprotein-cholesterol levels during psychopharmacological treatment - a cross-sectional naturalistic study. Psychiatry Research. 327-336.
  • 2012. Genetic variants affecting the neural processing of human facial expressions: evidence using a genome-wide functional imaging approach. Translational Psychiatry.
  • 2012. Gene-based analysis of regionally enriched cortical genes in GWAS data sets of cognitive traits and psychiatric disorders. PLOS ONE. 14 pages.
  • 2012. Effect of DISC1 SNPs on Brain Structure in Healthy Controls and Patients With a History of Psychosis. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics. 722-730.
  • 2012. DCLK1 variants are associated across schizophrenia and attention deficit/hyperactivity disorder. PLOS ONE. 12 pages.
  • 2012. Connection between Genetic and Clinical Data in Bipolar Disorder. PLOS ONE. 9 pages.
  • 2012. Associations Between Variants Near a Monoaminergic Pathways Gene (PHOX2B) and Amygdala Reactivity: A Genome-Wide Functional Imaging Study. Twin Research and Human Genetics. 273-285.
  • 2012. Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans. Proceedings of the National Academy of Sciences of the United States of America. 3985-3990.
  • 2012. Association between a genetic variant in the serotonin transporter gene (SLC6A4) and suicidal behavior in patients with schizophrenia. Behavioral and Brain Functions. 8 pages.
  • 2011. The Complement Control-Related Genes CSMD1 and CSMD2 Associate to Schizophrenia. Biological Psychiatry. 35-42.
  • 2011. Syndecan-4 is essential for development of concentric myocardial hypertrophy via stretch-induced activation of the calcineurin-NFAT pathway. PLOS ONE.
  • 2011. Meta-Analysis of Heterogeneous Data Sources for Genome-Scale Identification of Risk Genes in Complex Phenotypes. Genetic Epidemiology. 318-332.
  • 2011. Maternally Derived Microduplications at 15q11-q13: Implication of Imprinted Genes in Psychotic Illness. American Journal of Psychiatry. 408-417.
  • 2011. Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4. Nature Genetics. 977-983.
  • 2011. Intron 12 in NTRK3 is associated with bipolar disorder. Psychiatry Research. 358-362.
  • 2011. Genome-wide association study identifies five new schizophrenia loci. Nature Genetics. 969-976.
  • 2011. Genome-wide Association Study Identifies Genetic Variation in Neurocan as a Susceptibility Factor for Bipolar Disorder. American Journal of Human Genetics. 372-381.
  • 2011. Expanding the range of ZNF804A variants conferring risk of psychosis. Molecular Psychiatry. 59-66.
  • 2011. Dual association of a TRKA polymorphism with schizophrenia. Psychiatric Genetics. 125-131.
  • 2011. Copy number variations of chromosome 16p13.1 region associated with schizophrenia. Molecular Psychiatry. 17-25.
  • 2011. Copy number variations in affective disorders and meta-analysis. Psychiatric Genetics. 319-322.
  • 2011. Common variants at VRK2 and TCF4 conferring risk of schizophrenia. Human Molecular Genetics. 4076-4081.
  • 2011. Common Sequence Variants in the Major Histocompatibility Complex Region Associate with Cerebral Ventricular Size in Schizophrenia. Biological Psychiatry. 696-698.
  • 2011. Combinations of SNPs Related to Signal Transduction in Bipolar Disorder. PLOS ONE. 11 pages.
  • 2011. Candidate Gene Analysis of the Human Natural Killer-1 Carbohydrate Pathway and Perineuronal Nets in Schizophrenia: B3GAT2 Is Associated with Disease Risk and Cortical Surface Area. Biological Psychiatry. 90-96.
  • 2011. At-Risk Variant in TCF7L2 for Type II Diabetes Increases Risk of Schizophrenia. Biological Psychiatry. 59-63.
  • 2011. Association of genetic variants on 15q12 with cortical thickness and cognition in schizophrenia. Archives of General Psychiatry. 781-790.
  • 2010. The Tryptophan Hydroxylase 1 (TPH1) Gene, Schizophrenia Susceptibility, and Suicidal Behavior: A Multi-Centre Case-Control Study and Meta-Analysis. American Journal of Medical Genetics. 387-396.
  • 2010. Sex-dependent association of common variants of microcephaly genes with brain structure. Proceedings of the National Academy of Sciences of the United States of America. 384-388.
  • 2010. Polymorphisms in SREBF1 and SREBF2, two antipsychotic-activated transcription factors controlling cellular lipogenesis, are associated with schizophrenia in German and Scandinavian samples. Molecular Psychiatry. 463-472.
  • 2010. Osteoprotegerin levels in patients with severe mental disorders. Journal of Psychiatry & Neuroscience. 304-310.
  • 2010. Gene variants associated with schizophrenia in a Norwegian genome-wide study are replicated in a large European cohort. Journal of Psychiatric Research. 748-753.
  • 2010. Catechol O-methyltransferase variants and cognitive performance in schizophrenia and bipolar disorder versus controls. Schizophrenia Research. 31-37.
  • 2010. Association Study of PDE48 gene variants in Scandinavian schizophrenia and bipolar disorder multicenter case-control samples. American Journal of Medical Genetics. 86-96.
  • 2010. Association Between Methylenetetrahydrofolate Reductase (MTHFR) C677T Polymorphism and Age of Onset in Schizophrenia. American Journal of Medical Genetics. 610-618.
  • 2010. Association Analysis of PALB2 and BRCA2 in Bipolar Disorder and Schizophrenia in a Scandinavian Case–Control Sample. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics. 1276-1280.
  • 2010. A large replication study and meta-analysis in European samples provides further support for association of AHI1 markers with schizophrenia. Human Molecular Genetics. 1379-1386.
  • 2010. A genome-wide association study of bipolar disorder in Norwegian individuals, followed by replication in Icelandic sample. Journal of Affective Disorders. 312-316.
  • 2009. Tyrosine hydroxylase Val81Met polymorphism: lack of association with schizophrenia. Psychiatric Genetics. 273-274.
  • 2009. Three-cohort targeted gene screening reveals a non-synonymous TRKA polymorphism associated with schizophrenia. Journal of Psychiatric Research. 1195-1199.
  • 2009. The Tryptophan hydroxylase 1 (TPH1) gene, schizophrenia susceptibility, and suicidal behavior: A multi-centre case-control study and meta-analysis. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics.
  • 2009. No association between DGKH and bipolar disorder in a Scandinavian case-control sample. Psychiatric Genetics. 269-272.
  • 2009. Evidence for a possible association of neurotrophin receptor (NTRK-3) gene polymorphisms with hippocampal function and schizophrenia. Neurobiology of Disease. 518-524.
  • 2009. Dysbindin and D-Amino-Acid-Oxidase Gene Polymorphisms Associated with Positive and Negative Symptoms in Schizophrenia. Neuropsychobiology. 31-36.
  • 2009. Disruption of the neurexin 1 gene is associated with schizophrenia. Human Molecular Genetics. 988-996.
  • 2009. DTNBP1, NRG1, DAOA, DAO and GRM3 Polymorphisms and Schizophrenia: An Association Study. Neuropsychobiology. 142-150.
  • 2009. Copy number variations of chromosome 16p13.1 region associated with schizophrenia. Molecular Psychiatry. 1-9.
  • 2009. Common variants conferring risk of schizophrenia. Nature. 744-747.
  • 2009. Association of MCTP2 gene variants with schizophrenia in three independent samples of Scandinavian origin (SCOPE). Psychiatry Research. 256-258.
  • 2009. Association between methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and age of onset in schizophrenia. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics.
  • 2009. A possible association between schizophrenia and GRIK3 polymorphisms in a multicenter sample of Scandinavian origin (SCOPE). Schizophrenia Research. 242-248.
  • 2009. A common MECP2 haplotype associates with reduced cortical surface area in humans in two independent populations. Proceedings of the National Academy of Sciences of the United States of America. 15483-15488.
  • 2008. Two methylenetetrahydrofolate reductase gene (MTHFR) polymorphisms, schizophrenia and bipolar disorder: An association study. American Journal of Medical Genetics. 976-982.
  • 2008. The estrogen hypothesis of schizophrenia implicates glucose metabolism: association study in three independent samples. BMC Medical Genetics. 39.
  • 2008. Polymorphisms in SREBF1 and SREBF2, two antipsychotic-activated transcription factors controlling cellular lipogenesis, are associated with schizophrenia in German and Scandinavian samples. Molecular Psychiatry.
  • 2008. Large recurrent microdeletions associated with schizophrenia. Nature. 232-U61.
  • 2008. Disruption of the neurexin 1 gene is associated with schizophrenia. Human Molecular Genetics.
  • 2008. Association between a disrupted-in-schizophrenia 1 (DISC1) single nucleotide polymorphism and schizophrenia in a combined Scandinavian case-control sample. Schizophrenia Research. 237-241.
  • 2008. Association Analysis of Schizophrenia on 18 Genes Involved in Neuronal Migration: MDGA1 as a New Susceptibility Gene. American Journal of Medical Genetics. 1089-1100.
  • 2008. A possible association between schizophrenia and GRIK3 polymorphisms in a multicenter sample of Scandinavian origin (SCOPE). Schizophrenia Research.
  • 2008. A novel myogenic cell line with phenotypic properties of muscle progenitors. Journal of Molecular Medicine. 105-115.
  • 2007. The effect of red wine on plasma leptin levels and vasoactive factors from adipose tissue: A randomized crossover trial. Alcohol and Alcoholism. 525-528.
  • 2007. Brief Research CommunicationTwo methylenetetrahydrofolate reductase gene (MTHFR) polymorphisms, schizophrenia and bipolar disorder: An association study. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics.
  • 2007. Brain expressed microRNAs implicated in schizophrenia etiology. PLOS ONE. e873.
  • 2005. Activity of peroxisomal enzymes, and levels of polyamines in LPA-transgenic mice on two different diets. Lipids in Health and Disease. 12 pages.
  • 2004. Variations in transfection efficiency of VEGF(165) and VEGF(121)-cDNA - Its effects on proliferation and migration of human endothelial cells. Molecular Biotechnology. 7-16.
  • 2004. Human apoB contributes to increased serum total apo(a) level in LPA transgenic mice. Lipids in Health and Disease. 8.
  • 2004. Comparison of nonviral transfection and adeno-associated viral transduction on cardiomyocytes. Molecular Biotechnology. 21-31.
Academic lecture
  • 2018. Affective lability and polygenic risk in bipolar disorder.
  • 2017. Layer V pyramidal cells as mediators of delta oscillations: Insights from biophysically detailed modeling and connections with schizophrenia genetics.
  • 2017. Delta oscillations in schizophrenia: Insights from biophysically detailed modeling of networks of layer V pyramidal cells.
  • 2017. Conditional false discovery rate analysis of genome-wide association studies uncovers genetic loci shared between schizophrenia and volumes of hippocampus, putamen and intracranial volume.
  • 2016. Genetic overlap between schizophrenia and brain structural volumes indicates shared molecular genetic mechanisms with potential relevance for antipsychotics .
  • 2006. Syndecan-4 is an essential signal transducer for activation of the calcineurin-NFAT pathway and cardiac hypertrophy in mice.
  • 2005. Why syndecan-4 might be important in heart failure following myocardial infarction.
  • 2005. A role for syndecan-4 during development of heart failure following myocaridal infarction.
  • 2005. A role for syndecan-4 as a signal transducer during development of heart failure following myocardial infarction.
Abstract
  • 2019. Genome wide Association study: identifying Genetic markers in apathy in People with Alzheimer's disease. Alzheimer's & Dementia. P286-P286.
  • 2013. Is Met Variant of the BDNF VAL66MET-Combined with Childhood Trauma - A Risk Factor of Brain Abnormalities in Psychoses? Biological Psychiatry. 287S-287S.
  • 2012. Interactions between BDNF Val66Met gene polymorphism, childhood adverse events and brain volume changes in schizophrenia and bipolar disorder. Early Intervention in Psychiatry. 30-30.
  • 2012. Interaction between (BDNF) VAL66Met, childhood adverse events and impaired cognition in patients with schizophrenia spectrum and bipolar disorder. Early Intervention in Psychiatry. 45-45.
  • 2011. SEROTONIN TRANSPORTER GENE POLYMORPHISMS, CHILDHOOD TRAUMA AND COGNITION IN PATIENTS WITH PSYCHOTIC DISORDERS. Schizophrenia Bulletin. 80-80.
  • 2009. DYSBINDIN AND D-AMINO-ACID-OXIDASE GENE POLYMORPHISMS ASSOCIATED WITH POSITIVE AND NEGATIVE SYMPTOMS IN SCHIZOPHRENIA. Schizophrenia Bulletin. 105-105.
  • 2009. ASSOCIATION BETWEEN THE TRYPTOPHAN HYDROXYLASE 1 (TPH1) GENE, SCHIZOPHRENIA SUSCEPTIBILITY, AND SUICIDAL BEHAVIOR. Schizophrenia Bulletin. 121-121.
  • 2008. Interaction between health behaviour, mental distress and the polymorphism of the serotonin transporter gene among adolescents in Oslo, Norway. European psychiatry. S174-S174.
  • 2003. Effect of cholesterol feeding on apo(a), CYP7A1 and LXR alpha expression in LPA transgenic mice. Atherosclerosis Supplements. 296-296.
Academic literature review
  • 2020. Copy number variants (CNVs): A powerful tool for iPSC-based modelling of ASD. 1-18.
  • 2019. Discovery of shared genomic loci using the conditional false discovery rate approach. 1-10.
  • 2019. Biophysical Psychiatry—How Computational Neuroscience Can Help to Understand the Complex Mechanisms of Mental Disorders. 14 pages.
  • 2017. Genetic evidence for role of integration of fast and slow neurotransmission in schizophrenia. 792-801.
  • 2016. Modeling psychiatric disorders: From genomic findings to cellular phenotypes. 1167-1179.
  • 2010. SRD5A2 is associated with increased cortisol metabolism in schizophrenia spectrum disorders. 1500-1506.

More information in national current research information system (CRIStin)